Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial

This publication has 22 references indexed in Scilit:

• Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group
  Journal of Clinical Oncology, 2003
• Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
  JNCI Journal of the National Cancer Institute, 2003
• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors
  Annals of Oncology, 2001
• A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients
  Annals of Oncology, 2001
• Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial
  Journal of Clinical Oncology, 2001
• Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1999
• Cancer burden in the aged
  Cancer, 1997
• Patient preferences for oral versus intravenous palliative chemotherapy.
  Journal of Clinical Oncology, 1997
• Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
  Journal of Clinical Oncology, 1994